Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.

Baniwal SK, Khalid O, Gabet Y, Shah RR, Purcell DJ, Mav D, Kohn-Gabet AE, Shi Y, Coetzee GA, Frenkel B.

Mol Cancer. 2010 Sep 23;9:258. doi: 10.1186/1476-4598-9-258.

2.

Wnt inhibitory factor 1 is epigenetically silenced in human osteosarcoma, and targeted disruption accelerates osteosarcomagenesis in mice.

Kansara M, Tsang M, Kodjabachian L, Sims NA, Trivett MK, Ehrich M, Dobrovic A, Slavin J, Choong PF, Simmons PJ, Dawid IB, Thomas DM.

J Clin Invest. 2009 Apr;119(4):837-51. doi: 10.1172/JCI37175. Epub 2009 Mar 23.

3.

Wnt signaling in breast organogenesis.

Boras-Granic K, Wysolmerski JJ.

Organogenesis. 2008 Apr;4(2):116-22.

4.

Wnt pathway, an essential role in bone regeneration.

Chen Y, Alman BA.

J Cell Biochem. 2009 Feb 15;106(3):353-62. doi: 10.1002/jcb.22020. Review.

PMID:
19127541
5.

Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.

Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM.

Oncogene. 2009 Feb 19;28(7):1005-15. doi: 10.1038/onc.2008.454. Epub 2008 Dec 15.

PMID:
19079339
6.

Breast cancer-derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases.

Bu G, Lu W, Liu CC, Selander K, Yoneda T, Hall C, Keller ET, Li Y.

Int J Cancer. 2008 Sep 1;123(5):1034-42. doi: 10.1002/ijc.23625.

7.

Increased COX2 expression enhances tumor-induced osteoclastic lesions in breast cancer bone metastasis.

Li Z, Schem C, Shi YH, Medina D, Zhang M.

Clin Exp Metastasis. 2008;25(4):389-400. Epub 2007 Oct 27.

PMID:
17965942
8.

Beta-catenin signaling plays a disparate role in different phases of fracture repair: implications for therapy to improve bone healing.

Chen Y, Whetstone HC, Lin AC, Nadesan P, Wei Q, Poon R, Alman BA.

PLoS Med. 2007 Jul 31;4(7):e249.

9.

The Wnt signaling pathway and bone metabolism.

Johnson ML, Kamel MA.

Curr Opin Rheumatol. 2007 Jul;19(4):376-82. Review.

PMID:
17551370
10.

Wnt pathway and breast cancer.

Mohinta S, Wu H, Chaurasia P, Watabe K.

Front Biosci. 2007 May 1;12:4020-33. Review.

PMID:
17485355
11.

Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.

Schwaninger R, Rentsch CA, Wetterwald A, van der Horst G, van Bezooijen RL, van der Pluijm G, Löwik CW, Ackermann K, Pyerin W, Hamdy FC, Thalmann GN, Cecchini MG.

Am J Pathol. 2007 Jan;170(1):160-75.

12.

Beta-catenin signaling pathway is crucial for bone morphogenetic protein 2 to induce new bone formation.

Chen Y, Whetstone HC, Youn A, Nadesan P, Chow EC, Lin AC, Alman BA.

J Biol Chem. 2007 Jan 5;282(1):526-33. Epub 2006 Nov 3.

13.

Regulation of cancer cell migration and bone metastasis by RANKL.

Jones DH, Nakashima T, Sanchez OH, Kozieradzki I, Komarova SV, Sarosi I, Morony S, Rubin E, Sarao R, Hojilla CV, Komnenovic V, Kong YY, Schreiber M, Dixon SJ, Sims SM, Khokha R, Wada T, Penninger JM.

Nature. 2006 Mar 30;440(7084):692-6.

PMID:
16572175
14.

Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.

Spencer GJ, Utting JC, Etheridge SL, Arnett TR, Genever PG.

J Cell Sci. 2006 Apr 1;119(Pt 7):1283-96. Epub 2006 Mar 7.

15.

Prostate cancer cells promote osteoblastic bone metastases through Wnts.

Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET.

Cancer Res. 2005 Sep 1;65(17):7554-60.

16.

Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression.

Gaur T, Lengner CJ, Hovhannisyan H, Bhat RA, Bodine PV, Komm BS, Javed A, van Wijnen AJ, Stein JL, Stein GS, Lian JB.

J Biol Chem. 2005 Sep 30;280(39):33132-40. Epub 2005 Jul 25.

17.

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy.

Kozlow W, Guise TA.

J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):169-80. Review.

PMID:
16025223
18.

Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes.

Hill TP, Später D, Taketo MM, Birchmeier W, Hartmann C.

Dev Cell. 2005 May;8(5):727-38.

19.

The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer.

González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A.

Oncogene. 2005 Feb 3;24(6):1098-103.

PMID:
15592505
20.

Wnt signaling in osteoblasts and bone diseases.

Westendorf JJ, Kahler RA, Schroeder TM.

Gene. 2004 Oct 27;341:19-39. Review.

PMID:
15474285

Supplemental Content

Support Center